Year: 2026
Type: article
Abstract: Cancer constitutes the primary and foremost cause of death globally. Despite the emergence of numerous contemporary therapies alongside traditional therapy, mortality rates continue to escalate. Recently, immunotherapy has emerged as an attractive and advantageous method for cancer treatment. Despite its increasing use in the treatment of various cancer types, its efficacy varies considerably and is not uniformly superior to conventional treatment methods. Not every patients or tumor types responds effectively to immunotherapy. Increasing evidence indicates that this limited efficacy may be directly associated with immunosuppressive tumor microenvironment (TME). TME constitutes a dynamic immunological niche that regulates carcinogenesis, progression, and metastasis through various types of regulatory immune cells. These cells include myeloid-derived suppressor cells (MDSCs), regulatory T cells (Treg), and tumor-associated macrophages (TAMs) which foster immune evasion by repressing effective antitumor responses. An emerging class of plant-based anticancer compounds, terpenoids, have recently attracted attention for their potential immunomodulatory and anticancer properties. While previous research has mainly investigated their direct cytotoxic effects on tumor cells, recent findings from preclinical in vitro and in vivo studies suggest that terpenoids may also modulate immune regulatory networks within the TME. This narrative review provides a mechanistic overview of immunomodulatory potential of plant-derived terpenoids by regulating the activity of regulatory T cells (Treg) and myeloid-derived suppressor cells (MDSCs) within the TME in preclinical cancer models. It also highlighted the molecular mechanisms underlying plant-derived-induced alterations in Treg and MDSCs activity and function, including changes in signaling pathways, transcriptional regulatory factors, and cytokine mediated pathways.
Source: Frontiers in Pharmacology
Authors: Mohammad Alzahrani(Conceptualization, Formal analysis, Investigation, Writing – original draft, Writing – review & editing), Shakilur Rahman(Conceptualization, Formal analysis, Methodology, Writing – original draft), Md Ali Mujtaba(Conceptualization, Formal analysis, Supervision, Writing – review & editing), Meenakshi Verma(Formal analysis, Investigation, Visualization, Writing – review & editing), Pratibha Pandey(Conceptualization, Formal analysis, Validation, Writing – review & editing), Sorabh Lakhanpal(Formal analysis, Investigation, Supervision, Writing – review & editing), Shailendra Thapliyal(Formal analysis, Investigation, Validation, Writing – review & editing), Fahad Khan(Conceptualization, Project administration, Supervision, Writing – original draft, Writing – review & editing)
Language: English
Topic: Immune cells in cancer
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $3,801
Funder: Northern Borders University
Award: G9001398442
OpenAlex ID: W7236774620
